Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Alcon Inc. Investors Alcon Reports Second-Quarter 2024 Results with Strong Growth in Implantables and Contact Lenses August 20, 2024 From Alcon Inc. Investors Via Business Wire Tickers ALC Alcon’s Latest Equipment Breakthrough Technologies, Unity VCS and Unity CS, Receive U.S. FDA 510(k) Clearance June 24, 2024 From Alcon Inc. Investors Via Business Wire Tickers ALC Alcon Reports Strong First-Quarter 2024 Results Driven by Robust Sales in Contact Lenses and Ocular Health May 13, 2024 From Alcon Inc. Investors Via Business Wire Tickers ALC Alcon Announces Results of 2024 Annual General Meeting May 08, 2024 From Alcon Inc. Investors Via Business Wire Tickers ALC Alcon Publishes Agenda for 2024 Annual General Meeting April 07, 2024 From Alcon Inc. Investors Via Business Wire Tickers ALC Alcon's Broad Portfolio Delivers Robust Sales and Earnings Growth in FY 2023 February 27, 2024 From Alcon Inc. Investors Via Business Wire Tickers ALC Alcon Announces Positive Topline Results From Phase 3 COMET Trials of AR-15512, a Novel Topical Drug Candidate for Dry Eye January 09, 2024 From Alcon Inc. Investors Via Business Wire Tickers ALC Alcon to Present at 2024 Annual J.P. Morgan Healthcare Conference December 27, 2023 From Alcon Inc. Investors Via Business Wire Tickers ALC Alcon Reports Third Quarter 2023 Results November 14, 2023 From Alcon Inc. Investors Via Business Wire Tickers ALC Alcon Showcases Cloud-based Planning and World-class Digital Technologies During AAO 2023 October 30, 2023 From Alcon Inc. Investors Via Business Wire Tickers ALC Alcon Launches TOTAL30 Multifocal Contact Lenses for Patients with Presbyopia October 10, 2023 From Alcon Inc. Investors Via Business Wire Tickers ALC Alcon Reports Second Quarter 2023 Results August 15, 2023 From Alcon Inc. Investors Via Business Wire Tickers ALC Alcon Reports First Quarter 2023 Results May 09, 2023 From Alcon Inc. Investors Via Business Wire Tickers ALC New Head-to-Head Data Show Clareon Monofocal IOLs and TECNIS Eyhance Monofocal IOLs Provide Similar Range of Vision May 06, 2023 From Alcon Inc. Investors Via Business Wire Tickers ALC Alcon Announces Results of 2023 Annual General Meeting May 05, 2023 From Alcon Inc. Investors Via Business Wire Tickers ALC Alcon Announces Largest-Ever Scientific Presence at ASCRS 2023 and Expands Image-Guided Connectivity May 01, 2023 From Alcon Inc. Investors Via Business Wire Tickers ALC Alcon Publishes Agenda for 2023 Annual General Meeting March 29, 2023 From Alcon Inc. Investors Via Business Wire Tickers ALC Alcon to Host 2023 Capital Markets Day March 20, 2023 From Alcon Inc. Investors Via Business Wire Tickers ALC Alcon Reports Fourth Quarter and Full Year 2022 Results February 27, 2023 From Alcon Inc. Investors Via Business Wire Tickers ALC Alcon Announces Settlement of Litigation Related to Femtosecond Laser Assisted Cataract Surgery Devices February 12, 2023 From Alcon Inc. Investors Via Business Wire Tickers ALC Alcon Introduces a Premium, Reusable Toric Lens with Launch of TOTAL30 for Astigmatism January 05, 2023 From Alcon Inc. Investors Via Business Wire Tickers ALC Alcon to Present at 2023 Annual J.P. Morgan Healthcare Conference December 28, 2022 From Alcon Inc. Investors Via Business Wire Tickers ALC Alcon Prices US$1.3 Billion Senior Notes Offering November 29, 2022 From Alcon Inc. Investors Via Business Wire Tickers ALC Alcon Completes Acquisition of Aerie Pharmaceuticals, Inc., Strengthening Company’s Ophthalmic Pharmaceutical Business November 22, 2022 From Alcon Inc. Investors Via Business Wire Tickers AERI ALC Alcon Reports Third Quarter 2022 Results November 15, 2022 From Alcon Inc. Investors Via Business Wire Tickers ALC Alcon to Celebrate 75 Years of Brilliance and Showcase Contact Lens Innovations at #Academy22 October 26, 2022 From Alcon Inc. Investors Via Business Wire Tickers ALC Alcon Completes Availability of Clareon Portfolio with Clareon Toric During AAO 2022 September 29, 2022 From Alcon Inc. Investors Via Business Wire Tickers ALC Alcon to Acquire Aerie Pharmaceuticals, Inc., Enhancing its Ophthalmic Pharmaceutical Portfolio August 22, 2022 From Alcon Inc. Investors Via Business Wire Tickers AERI ALC Alcon Reports Second Quarter 2022 Results August 09, 2022 From Alcon Inc. Investors Via Business Wire Tickers ALC Alcon Prices EUR 500.0 Million Senior Notes Offering May 24, 2022 From Alcon Inc. Investors Via Business Wire Tickers ALC Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.